All sites C00-96,D32-33,D42-43,D45-47,D76 664 91.7 2.3 1.9 2.3 1.7
Mouth, pharynx C00-14 13 100.0 - - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 3 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 4 100.0 - - - -
Digestive organs C15-26 135 88.0 1.8 2.7 4.9 2.7
  Oesophagus C15 7 97.2 - - 2.8 -
  Stomach C16 15 94.6 - - 2.7 2.7
  Small intestine C17 3 93.8 6.3 - - -
  Colon C18 40 98.0 - 1.0 0.5 0.5
  Rectum, rectosigmoid C19-20 27 99.3 - - 0.7 -
  Anus C21 0 100.0 - - - -
  Liver C22 13 81.0 6.3 3.2 6.3 3.2
  Gallbladder, bile ducts C23-24 4 83.3 5.6 - 11.1 -
  Pancreas C25 25 56.9 4.9 11.4 17.9 8.9
  Other digestive organs C26 2 77.8 - - - 22.2
Respiratory organs C30-39 72 73.0 11.4 7.8 5.3 2.5
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 7 100.0 - - - -
  Lung, trachea C33-34 64 69.7 12.8 8.8 5.9 2.8
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 1 71.4 28.6 - - -
Melanoma of the skin C43 26 100.0 - - - -
Skin, non-melanoma C44 42 100.0 - - - -
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 4 100.0 - - - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 215 99.3 - 0.1 0.6 -
  Prostate C61 207 99.3 - 0.1 0.6 -
  Testis C62 6 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 64 94.3 0.9 1.9 0.9 1.9
  Kidney C64 26 87.6 0.8 4.7 2.3 4.7
  Bladder and urinary tract2 C65-68 38 98.9 1.1 - - -
Eye C69 1 60.0 - 20.0 20.0 -
Brain, central nervous system C70-72,D32-33,D42-43 16 98.8 - - 1.3 -
Thyroid gland C73 4 100.0 - - - -
Other endocrine glands C74-75 1 71.4 - 28.6 - -
Illdefined or unknown C76,C80 9 71.1 4.4 6.7 4.4 13.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 57 82.2 5.2 1.7 4.5 6.3
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 22 99.1 - - 0.9 -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 11 68.5 5.6 7.4 9.3 9.3
  Leukaemia C91-95 14 69.6 14.5 1.4 4.3 10.1
  Myelodysplastic syndromes D46 2 33.3 8.3 - 16.7 41.7
  Myeloproliferaitive neoplasms D45,D47 6 87.1 3.2 - 6.5 3.2
Not included above
  Basal cell carcinoma of the skin 159 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.